- Product Details
Keywords
- Imatinib Mesylate powder
- CAS:220127-57-1 Imatinib Mesylate
- Anticancer API Imatinib Mesylate
Quick Details
- ProName: IMATINIB MESYLATE CAS:220127-57-1
- CasNo: 220127-57-1
- Molecular Formula: C30H35N7O4S
- Appearance: White or slightly yellow crystalline p...
- Application: Anticancer
- DeliveryTime: within 7-10 days after order
- PackAge: 1kg/tin or per customer's requirement
- Port: Beijing/Shanghai/Hangzhou/Shenzhen
- ProductionCapacity: 1000 Kilogram/Month
- Purity: 99%
- LimitNum: 1 Kilogram
- Residue on Ignition: ≤0.1%
- Heavy Metal: ≤20ppm
- Valid Period: 2 years
- Water: ≤1.0%
Superiority
1) Specialized in pharmaceutical industry since from 1987
2) ISO 9001:2015 & SGS audited supplier
3) Accept better payment terms : T.T 30-60 days.on the basic of pass SINOSURE credit investigation.
5) We have warehouse in USA with quickly shipment .
6) We can do different terms of FOB ,CIF/CIP ,DDP ...
Details
Product Information |
Product name |
Imatinib Mesylate |
Molecular Formula |
C30H35N7O4S |
Molecular Weight |
589.71 |
CAS No. |
220127-57-1 |
Quality Standard |
In-house standard |
Appearance |
White powder |
COA of Imatinib Mesylate |
TEST ITEMS |
SPECIFICATION |
RESULTS |
Appearance |
White or slightly yellow crystalline powder, |
Slightly yellow crystalline Powder |
Solubility |
Soluble in water and in acids solutions, slightly soluble |
Confirm |
Identification |
Complies |
Confirm |
Water |
≤1.0% |
0.8% |
Heavy metals |
≤20ppm |
10ppm |
Melting range |
212 – 220℃ |
214-216℃ |
Residue on ignition |
≤0.1% |
0.08% |
Particle size |
90% < 100 μm 50% < 50 μm |
Confirm |
Bulk density |
NLT 0.4g/ml |
0.6g/ml |
Chromatographic purity |
Individual impurities: ≤0.2% Total impurities: ≤0.5% |
0.16% 0.32% |
Assay |
98.5%-102.0% of Imatinib mesylate, calculated on anhydrous basis. |
99.70% |
Residual solvents |
Ethyl acetate: ≤5000ppm |
Confirm |
Acetone: ≤5000ppm |
Confirm |
|
N,N-Dimethylformamide: ≤880ppm |
Confirm |
|
Methanol: ≤3000ppm |
Confirm |
|
Dichloromethane: ≤300ppm |
Confirm |
We provide you with high-quality imatinib mesylate powder and imatinib mesylate price is very reasonable and competitive.
Usage |
Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia. As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.
1. A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)
2. Echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis
3. Anticancer